Omega Healthcare Investors Inc.
OHI
$47.90
-0.75%
Omega Healthcare Investors Inc. is a real estate investment trust (REIT) specializing in healthcare-related real estate, primarily skilled nursing facilities, assisted living facilities, and other senior housing properties across the United States, the United Kingdom, and Canada. The company operates as a capital partner to third-party healthcare operators, positioning itself as a key financier in the essential but often challenging post-acute care real estate sector. The current investor narrative centers on the company's recovery trajectory following pandemic-era operator distress, with recent attention focused on stabilizing rent collections, portfolio repositioning, and the sustainability of its high dividend yield amidst evolving healthcare reimbursement and demographic trends.…
OHI
Omega Healthcare Investors Inc.
$47.90
Related headlines
Investment Opinion: Should I buy OHI Today?
Rating & Thesis: Hold. OHI is a fundamentally recovered company trading at a full valuation, making the risk/reward balanced at current levels. The mixed analyst sentiment, with recent downgrades amid a general 'Hold' consensus, supports a neutral stance. The core thesis is that the impressive operational turnaround is now fully reflected in the stock price.
Supporting Evidence: The stock trades at a forward P/E of 23.37x and a PS ratio of 10.96x, which are at a premium to its own history and many REIT peers. While revenue growth is strong at 15.22% YoY and profitability is exceptional (51.18% net margin), these positives are offset by a high payout ratio of 132% and recent relative strength weakness (-4.10% over 3 months). The lack of a clear analyst price target consensus further muddies the implied upside picture, suggesting limited conviction for further near-term appreciation.
Risks & Conditions: The two biggest risks are valuation multiple contraction and a slowdown in revenue growth. This Hold rating would upgrade to a Buy if the P/E multiple compressed meaningfully below 20x on sustained earnings, or if revenue growth re-accelerated above 20% YoY, signaling a new growth phase. It would downgrade to a Sell if quarterly revenue growth decelerated below 5% YoY or if FCF generation weakened, threatening the dividend. Based on current metrics, the stock is fairly valued to slightly overvalued relative to its near-term growth prospects.
Sign up to view all
OHI 12-Month Price Forecast
The outlook for OHI is one of stabilization after a powerful rally. The company's operational health is the best it has been in years, but the market has justly rewarded it, leaving the stock fairly valued. Over the next 12 months, the most likely path is range-bound trading, with the high yield constituting the majority of total return. The stance would turn bullish on evidence of a new growth leg (e.g., accretive acquisitions) or a valuation reset to a more attractive level. It would turn bearish on any deterioration in operator cash flows or a breakdown below key technical support near $44.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omega Healthcare Investors Inc.'s 12-month outlook, with a consensus price target around $62.27 and implied upside of +30.0% versus the current price.
Average Target
$62.27
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$38 - $62
Analyst target range
Analyst coverage for OHI appears limited, with only 3 analysts providing revenue estimates, and no explicit consensus price target or recommendation data provided in the dataset. The institutional ratings data shows recent activity from several firms, with a mix of 'Hold'/'Sector Perform' (Wells Fargo, Truist, Scotiabank, RBC) and 'Buy'/'Overweight' (Cantor Fitzgerald, UBS) ratings, though one notable downgrade occurred in January 2026 when Wells Fargo moved from Overweight to Equal Weight. This pattern suggests a neutral to cautiously optimistic consensus sentiment among covering analysts. Without a clear average target price, the implied upside cannot be calculated, and the target range remains undefined. The presence of both upgrades and downgrades in recent months indicates ongoing debate about the stock's near-term prospects, likely tied to interest rate sensitivity and operator health. The limited explicit coverage and mixed institutional ratings signal that while the company is followed by major firms, it may not command the breadth of coverage of larger-cap peers, which can contribute to higher volatility as news and earnings are interpreted by a smaller pool of market participants.
Bulls vs Bears: OHI Investment Factors
The evidence currently tilts slightly bullish, supported by demonstrable fundamental recovery in revenue, soaring profitability, and strong cash generation. However, the bear case is formidable, centered on a valuation that appears full after a 32% rally, leaving little margin for error. The single most important tension in the investment debate is whether OHI's current premium valuation (22.25x P/E) is justified by a new, sustainably higher level of earnings and cash flow post-recovery, or if it represents a cyclical peak that will compress with any hint of operator weakness or rising interest rates. The resolution of this valuation sustainability question will dictate the stock's direction more than any other factor.
Bullish
- Strong Revenue Growth & Recovery: Q4 2025 revenue grew 15.22% YoY to $321.8 million, accelerating from $276.8 million in Q1 2025. This sequential improvement signals a robust recovery in operator health and rent collections, the core of OHI's business model.
- Exceptional Profitability & Margins: The company boasts a Q4 net margin of 51.18% and an operating margin of 63.49%. Net income grew from $109.0M in Q1 to $164.7M in Q4, demonstrating significant operating leverage and effective cost management as the portfolio stabilizes.
- Robust Cash Flow & Dividend Coverage: Trailing twelve-month free cash flow of $859.8 million provides a strong foundation. With a current ratio of 3.46 and a debt-to-equity ratio of 0.82, the balance sheet is healthy, supporting the sustainability of its 5.94% dividend yield.
- Technical Uptrend & Market Outperformance: The stock has gained 32.36% over the past year, outperforming the S&P 500's 27.43% gain. Trading at 97.8% of its 52-week high ($49.33) indicates strong momentum and investor confidence in the recovery thesis.
Bearish
- Full Valuation & Limited Upside: Trading at a trailing P/E of 22.25x and a forward P/E of 23.37x, the stock is near the upper end of its historical valuation range. The elevated PS ratio of 10.96x suggests much of the recovery is priced in, limiting potential for multiple expansion.
- Recent Momentum Divergence: While the 1-year trend is strong, recent 1-month (+5.03%) and 3-month (+3.63%) gains underperformed the S&P 500 (+5.49% and +7.73%). This deceleration, coupled with the stock testing major resistance, raises short-term consolidation risks.
- High Payout Ratio & Yield Sustainability: The payout ratio is 132.24%, indicating dividends are being paid from sources other than current-period earnings. Although supported by strong FCF, this highlights dependence on non-recurring items or balance sheet strength, a risk if operator distress re-emerges.
- Mixed Analyst Sentiment & Limited Coverage: Institutional ratings show a mix of Hold/Sector Perform and Buy ratings, with a notable downgrade (Wells Fargo, Jan 2026). With only 3 analysts providing revenue estimates, the stock lacks broad consensus support, which can lead to higher volatility.
OHI Technical Analysis
The stock is in a sustained uptrend, evidenced by a robust 1-year price change of +32.36%, significantly outperforming the broader market's +27.43% gain. Currently trading at $48.26, the price sits at approximately 97.8% of its 52-week high of $49.33, indicating the stock is testing major resistance levels near its recent peak. This positioning suggests strong momentum but also raises the risk of a pullback if the resistance level holds, as the stock is extended and may be overbought in the short term. Recent momentum shows a positive but decelerating trend, with a 1-month gain of +5.03% and a 3-month gain of +3.63%, both underperforming the S&P 500's respective gains of +5.49% and +7.73%. This divergence from the stronger long-term trend could signal a period of consolidation or a temporary pause in the rally as the stock digests its significant gains. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $49.33 and support at the 52-week low of $35.70. A decisive breakout above $49.33 could signal a continuation of the bullish trend, while a failure could lead to a retest of lower support levels. The stock's beta of 0.587 indicates it is approximately 41% less volatile than the broader market, which is typical for a REIT and suggests it may offer a smoother ride for income-focused investors, though its recent price action near highs warrants caution.
Beta
0.59
0.59x market volatility
Max Drawdown
-9.5%
Largest decline past year
52-Week Range
$36-$49
Price range past year
Annual Return
+33.1%
Cumulative gain past year
| Period | OHI Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | +4.4% |
| 3m | +2.9% | +9.3% |
| 6m | +6.3% | +10.5% |
| 1y | +33.1% | +28.8% |
| ytd | +7.6% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OHI Fundamental Analysis
Revenue growth has been strong and accelerating, with Q4 2025 revenue of $321.8 million representing a 15.22% year-over-year increase. This growth trend is consistent, as quarterly revenue has climbed sequentially from $276.8 million in Q1 2025 to the current level, indicating a robust recovery in the underlying business. The primary driver is likely improved operator performance and rent collections across its portfolio of skilled nursing and assisted living facilities. The company is solidly profitable, with Q4 2025 net income of $164.7 million and a net margin of 51.18%. Gross margin for the quarter was 47.22%, while the operating margin was a strong 63.49%. Profitability metrics have shown improvement, with net income rising from $109.0 million in Q1 2025, demonstrating effective cost management and the benefits of a stabilized operating environment. The balance sheet and cash flow position are healthy, with a conservative debt-to-equity ratio of 0.82 and a robust current ratio of 3.46, indicating strong liquidity. The company generated substantial free cash flow of $859.8 million on a trailing twelve-month basis, providing ample coverage for its dividend obligations. Return on equity stands at 11.39%, which is reasonable for a REIT, and the strong cash generation supports the company's ability to fund growth internally and maintain its dividend.
Quarterly Revenue
$321817000.0B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$859844000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OHI Overvalued?
Given the positive net income of $164.7 million in the latest quarter, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 22.25x, while the forward P/E is slightly higher at 23.37x, suggesting the market expects modest earnings growth or is pricing in a stable earnings profile for this income-oriented REIT. Compared to the broader REIT sector, a P/E in the low 20s is generally in line with or at a slight premium to many equity REITs, but this must be contextualized with its specific healthcare focus and dividend yield. The stock trades at a significant premium on a Price-to-Sales basis, with a PS ratio of 10.96x, and an EV/EBITDA of 14.84x, which are elevated but may reflect the high-margin, contractual nature of its rental income. Historically, the stock's current trailing P/E of 22.25x is near the upper end of its own range over the past several years, as seen in historical data where the P/E has fluctuated between single digits and the mid-20s. Trading near historical valuation highs suggests the market has largely priced in the company's recovery story and stable outlook, leaving less room for multiple expansion and making future returns more dependent on dividend income and fundamental earnings growth.
PE
22.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage—the debt-to-equity ratio of 0.82 is conservative—but earnings quality and dividend sustainability. The payout ratio of 132% is a red flag, indicating the dividend is not fully covered by net income, though robust FCF of $859.8M provides a cushion. Revenue concentration in the volatile skilled nursing sector, which faced severe operator distress during the pandemic, remains a key vulnerability. A deceleration from the current 15.22% YoY revenue growth rate could quickly pressure the elevated valuation multiples.
Market & Competitive Risks: The stock faces significant valuation compression risk, trading at a forward P/E of 23.37x and a PS ratio of 10.96x, which are premiums to many REITs. Its low beta of 0.587 offers some defensive characteristics but does not immunize it from sector-wide sell-offs in REITs, often triggered by rising interest rates. Competitive and regulatory risks are ever-present in healthcare, where changes in government reimbursement (Medicare/Medicaid) can directly impact operator profitability and, by extension, OHI's rent collections. The recent underperformance versus the S&P 500 over 3 months (-4.10% relative strength) may signal early rotation away from the story.
Worst-Case Scenario: The worst-case scenario involves a return of widespread operator distress, perhaps triggered by a new healthcare crisis or a sharp tightening of reimbursement rates. This would lead to rent deferrals or defaults, collapsing the high-margin earnings stream. Combined with a rising rate environment that compresses REIT multiples, the stock could re-test its 52-week low of $35.70. From the current price of $48.26, this represents a realistic downside of approximately -26%. A breach below that level could occur if investor sentiment towards the healthcare facility sector sours dramatically, as hinted at by bearish news on peers.
FAQ
The key risks are: 1) Operator Risk: The health of third-party nursing home operators is paramount; renewed distress would directly impact rent collections (the core revenue stream). 2) Valuation Risk: Trading near historical highs (P/E of 22.25x), the stock is vulnerable to multiple compression if growth slows or interest rates rise. 3) Dividend Sustainability Risk: The 132% payout ratio indicates the dividend is not fully covered by earnings, relying on strong free cash flow, which could be volatile. 4) Sector Sentiment Risk: Negative headlines or troubles for healthcare REIT peers can drag down OHI's valuation regardless of its specific performance.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $46 and $50, as stabilized growth supports the high yield but full valuation caps upside. The Bull Case (25% probability) targets $52 to $56, driven by multiple expansion and accelerating growth. The Bear Case (15% probability) warns of a drop to $36-$40 if operator problems resurface. The most likely outcome is the Base Case, predicated on the assumption that the strong post-pandemic recovery has peaked and will now normalize.
OHI appears fairly valued to slightly overvalued. Its trailing P/E of 22.25x is at the higher end of its historical range, and its Price-to-Sales ratio of 10.96x is elevated, suggesting the market has priced in the operational recovery. While the PEG ratio of 0.78 hints at value relative to growth, this is offset by a high payout ratio of 132%. Compared to the broader REIT sector, it trades at a premium. The valuation implies the market expects stable, high-margin earnings to continue with no major operational setbacks.
OHI is a good buy for a specific investor profile: those seeking high current income (5.94% yield) from a company with a stabilized fundamental base. However, for investors seeking capital appreciation, it is less attractive at current levels, as the valuation is full (22.25x P/E) after a 32% rally. The biggest downside risk is a return of operator distress, which could challenge the dividend and compress the multiple. It is a good buy for income-focused, patient investors who can accept moderate volatility, but not for growth-oriented traders.
OHI is more suitable for a long-term investment horizon (minimum 2-3 years). Its low beta of 0.587 indicates lower volatility than the market, which is typical for income-generating REITs held for yield. The investment thesis relies on the durability of operator recovery and consistent dividend payments, which are longer-term propositions. Short-term trading is challenged by the stock's position near 52-week highs and recent momentum divergence. For total return, investors should be prepared to hold through cycles to collect the dividend while waiting for the next fundamental or valuation catalyst.